NR
Nagabrahmachary Ravutla
About Nagabrahmachary Ravutla
Data last updated:
Nagabrahmachary Ravutla has 3 years in corporate governance. Holds Director role. Currently with 3 companies, including Ingenix Pharma Private Limited and Medione Enterprises (Opc) Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medione Enterprises (Opc) Private Limited U21003TS2025OPC197516 | Director | 23 Apr 2025 | 2025 | – | Active |
| Ravyn Life Sciences Private Limited U21009TS2025PTC193232 | Director | 23 Jan 2025 | 2025 | – | Active |
| Ingenix Pharma Private Limited U24290TG2022PTC167835 | Director | 31 Oct 2022 | 2022 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nagabrahmachary Ravutla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nagabrahmachary Ravutla
Nagabrahmachary Ravutla has 3 years in corporate governance. Holds Director role. Currently with 3 companies, including Ingenix Pharma Private Limited and Medione Enterprises (Opc) Private Limited. Engaged in General Business. Contributes to corporate operations.
Nagabrahmachary Ravutla is associated with 3 companies as Director, including Medione Enterprises (Opc) Private Limited, Ravyn Life Sciences Private Limited, Ingenix Pharma Private Limited.
Nagabrahmachary Ravutla has expertise in General Business.
Nagabrahmachary Ravutla has 3 years in corporate governance.
Nagabrahmachary Ravutla currently holds positions at 3 companies: Medione Enterprises (Opc) Private Limited, Ravyn Life Sciences Private Limited, Ingenix Pharma Private Limited.